Inspire Medical Systems, Inc. (INSP) Operating margin 2016–2025
Inspire Medical Systems, Inc. (INSP) operating margin by fiscal year — reported operating income divided by reported revenue.
5.6%FY2025 · since FY2016: -105.0% → 5.6%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | 5.6% | +1.1 pp |
| FY2024 | 4.5% | +10.9 pp |
| FY2023 | -6.4% | +5.2 pp |
| FY2022 | -11.7% | +5.4 pp |
| FY2021 | -17.1% | +31.6 pp |
| FY2020 | -48.7% | -6.2 pp |
| FY2019 | -42.5% | -2.3 pp |
| FY2018 | -40.3% | +15.7 pp |
| FY2017 | -56.0% | +49.0 pp |
| FY2016 | -105.0% | — |
Operating margin = reported operating income ÷ reported revenue for the same fiscal year. Operating-loss years show as a negative margin.
Source: SEC XBRL filings · For reference only · Not investment advice
More INSP financial trends
INSP RevenueINSP Net incomeINSP Net marginINSP Gross profitINSP Gross marginINSP Operating incomeINSP Operating cash flowINSP Free cash flowINSP Capital expendituresINSP Return on equityINSP Stock buybacksINSP Dividends paidINSP Total assetsINSP Total liabilitiesINSP Shareholders’ equityINSP overview →